{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:25:44Z","timestamp":1761675944055},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T00:00:00Z","timestamp":1336003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034142","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T20:57:27Z","timestamp":1336078647000},"page":"e34142","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Overexpression of the Catalytically Impaired Taspase1T234V or Taspase1D233A Variants Does Not Have a Dominant Negative Effect in T(4;11) Leukemia Cells"],"prefix":"10.1371","volume":"7","author":[{"given":"Carolin","family":"Bier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouven","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Scheiding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e","family":"W\u00fcnsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doroth\u00e9e","family":"Goesswein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver H.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley K.","family":"Knauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland H.","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias.","volume":"23","author":"C Meyer","year":"2009","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","article-title":"Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia.","volume":"117","author":"R Montes","year":"2011","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2009-06-229542","article-title":"The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.","volume":"115","author":"A Bursen","year":"2010","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/MCB.23.1.186-194.2003","article-title":"Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.","volume":"23","author":"JJ Hsieh","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/blood-2002-04-1015","article-title":"Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.","volume":"100","author":"A Yokoyama","year":"2002","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0092-8674(03)00816-X","article-title":"Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.","volume":"115","author":"JJ Hsieh","year":"2003","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1074\/jbc.M110.161646","article-title":"Cell-based Analysis of Structure-Function Activity of Threonine Aspartase 1.","volume":"286","author":"C Bier","year":"2011","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/sj.onc.1207837","article-title":"Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?","volume":"23","author":"A Bursen","year":"2004","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/leu.2010.308","article-title":"The heterodimerization domains of MLL-FYRN and FYRC-are potential target structures in t(4;11) leukemia.","volume":"25","author":"B Pless","year":"2011","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/leu.2010.249","article-title":"The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.","volume":"25","author":"A Benedikt","year":"2011","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.4161\/cbt.8.13.8924","article-title":"MLL fusions: pathways to leukemia.","volume":"8","author":"H Liu","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1742-4658.2010.07608.x","article-title":"Mixed lineage leukemia: roles in human malignancies and potential therapy.","volume":"277","author":"R Marschalek","year":"2010","journal-title":"Febs J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.str.2005.07.006","article-title":"Crystal structure of human Taspase1, a crucial protease regulating the function of MLL.","volume":"13","author":"JA Khan","year":"2005","journal-title":"Structure"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1074\/mcp.M700550-MCP200","article-title":"Targeting the human cancer pathway protein interaction network by structural genomics.","volume":"7","author":"YJ Huang","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cbpa.2009.05.125","article-title":"The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions.","volume":"13","author":"MR Arkin","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4161\/cc.7.11.6061","article-title":"Interfering with protein-protein interactions: potential for cancer therapy.","volume":"7","author":"T Tanaka","year":"2008","journal-title":"Cell Cycle"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/13543770903514129","article-title":"Patented inhibitors of p53-Mdm2 interaction (2006\u20132008).","volume":"20","author":"L Weber","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.leu.2403415","article-title":"The synthetic peptide PFWT disrupts AF4\u2013AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells.","volume":"18","author":"RS Srinivasan","year":"2004","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/0008-5472.CAN-06-3360","article-title":"Targeting the oligomerization domain of ETO interferes with RUNX1\/ETO oncogenic activity in t(8;21)-positive leukemic cells.","volume":"67","author":"C Wichmann","year":"2007","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e18253","DOI":"10.1371\/journal.pone.0018253","article-title":"Bioassays to monitor taspase1 function for the identification of pharmacogenetic inhibitors.","volume":"6","author":"SK Knauer","year":"2011","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.bmcl.2009.07.045","article-title":"Design, syntheses, and evaluation of Taspase1 inhibitors.","volume":"19","author":"JT Lee","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1600-0854.2005.00298.x","article-title":"Translocation biosensors to study signal-specific nucleo-cytoplasmic transport, protease activity and protein-protein interactions.","volume":"6","author":"SK Knauer","year":"2005","journal-title":"Traffic"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1600-0854.2011.01191.x","article-title":"The Importin-Alpha\/Nucleophosmin Switch Controls Taspase1 Protease Function.","volume":"12","author":"C Bier","year":"2011","journal-title":"Traffic"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1101\/gad.479209","article-title":"A phosphorylation-acetylation switch regulates STAT1 signaling.","volume":"23","author":"OH Kr\u00e4mer","year":"2009","journal-title":"Genes Dev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4161\/cc.6.12.4305","article-title":"The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.","volume":"6","author":"SK Knauer","year":"2007","journal-title":"Cell Cycle"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1128\/MCB.25.7.2573-2582.2005","article-title":"Nuclear export is evolutionarily conserved in CVC paired-like homeobox proteins and influences protein stability, transcriptional activation, and extracellular secretion.","volume":"25","author":"SK Knauer","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.embor.7400824","article-title":"The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.","volume":"7","author":"SK Knauer","year":"2006","journal-title":"EMBO Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.3700293","article-title":"Patient-based cross-platform comparison of oligonucleotide microarray expression profiles.","volume":"85","author":"J Schlingemann","year":"2005","journal-title":"Lab Investigation"},{"key":"ref29","article-title":"Nanoparticle size is a critical physico-chemical determinant of the human blood plasma corona - A comprehensive quantita-tive proteomic analysis.","volume":"nn-2011\u201301950e.R1","author":"S Tenzer","year":"2011","journal-title":"ACS Nano"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1038\/sj.onc.1202762","article-title":"Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans-dominant HTLV-1 rex mutants.","volume":"18","author":"P Heger","year":"1999","journal-title":"Oncogene"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1021\/ac050413o","article-title":"Development of an autofluorescent translocation biosensor system to investigate protein-protein interactions in living cells.","volume":"77","author":"SK Knauer","year":"2005","journal-title":"Anal Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/viro.1998.9295","article-title":"Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.","volume":"251","author":"RH Stauber","year":"1998","journal-title":"Virology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"25036","DOI":"10.1074\/jbc.M800963200","article-title":"The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.","volume":"283","author":"P Landgraf","year":"2008","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:58:03Z","timestamp":1539997083000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034142"}},"subtitle":[],"editor":[{"given":"Matthew","family":"Bogyo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034142","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]}}}